A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy

MLA

Xin Chen, et al. “A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy.” Frontiers in Oncology, vol. 11, June 2021. EBSCOhost, https://doi.org/10.3389/fonc.2021.679331.

APA

Xin Chen, Mary Jane Lim-Fat, Lei Qin, Angie Li, Annie Bryant, Camden P. Bay, Lu Gao, Nityanand Miskin, Zaiyi Liu, J. Bryan Iorgulescu, Xiaoyin Xu, David A. Reardon, & Geoffrey S. Young. (2021). A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.679331

Chicago

Xin Chen, Mary Jane Lim-Fat, Lei Qin, Angie Li, Annie Bryant, Camden P. Bay, Lu Gao, et al. 2021. “A Comparative Retrospective Study of Immunotherapy RANO Versus Standard RANO Criteria in Glioblastoma Patients Receiving Immune Checkpoint Inhibitor Therapy.” Frontiers in Oncology 11 (June). doi:10.3389/fonc.2021.679331.